AZ628   Click here for help

GtoPdb Ligand ID: 8475

Synonyms: AZ 628 | AZ-628
PDB Ligand
Compound class: Synthetic organic
Comment: AZ628 is an experimental inhibitor of RAF kinases [1]. Preclinical data for AZ628 was presented at the AACR Annual Meeting by Shen et al. in 2007 (Linking molecular characteristics to the pharmacological response of a panel of cancer cell lines to the BRAF inhibitor, AZ628).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 99.81
Molecular weight 451.2
XLogP 4.7
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#CC(c1cccc(c1)C(=O)Nc1ccc(c(c1)Nc1ccc2c(c1)c(=O)n(cn2)C)C)(C)C
Isomeric SMILES N#CC(c1cccc(c1)C(=O)Nc1ccc(c(c1)Nc1ccc2c(c1)c(=O)n(cn2)C)C)(C)C
InChI InChI=1S/C27H25N5O2/c1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23/h5-14,16,30H,1-4H3,(H,31,33)
InChI Key ZGBGPEDJXCYQPH-UHFFFAOYSA-N
References
1. Khazak V, Astsaturov I, Serebriiskii IG, Golemis EA. (2007)
Selective Raf inhibition in cancer therapy.
Expert Opin Ther Targets, 11 (12): 1587-609. [PMID:18020980]
2. Kolch W, Kotwaliwale A, Vass K, Janosch P. 
The role of Raf kinases in malignant transformation.
Accessed on 24/06/2015. Modified on 24/06/2015. www.expertreviews.org, http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.114.8626&rep=rep1&type=pdf
3. Wenglowsky S, Ren L, Grina J, Hansen JD, Laird ER, Moreno D, Dinkel V, Gloor SL, Hastings G, Rana S et al.. (2014)
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinase.
Bioorg Med Chem Lett, 24 (8): 1923-7. [PMID:24675381]